Botanix Pharmaceuticals jumps on supply agreement with PPL Pharma Solutions

Botanix Pharmaceuticals

16/04/2026 05:06

** Shares of Australia's Botanix Pharmaceuticals BOT.AX surge as much as 22.2% to A$0.04, their highest level since July 9, 2025

** Highest level since April 2

** Dermatology co reaches term sheet agreement with PPL Pharma Solutions Riverview for manufacturing and supply arrangement

** Under deal, PPL to start certain development services, serve as alternate commercial supplier of Sofpironium Bromide

** About 101.5 million shares change hands, 5.4 times the 30-day avg

** Down 71.1% YTD, including the session's moves

 (Reporting by Anjali Singh in Bengaluru)

 ((anjali.singh2@thomsonreuters.com;))